Search

everythinglearnresearchcommunity

for

Search:↓

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Children with autoimmune gastritis showed improved intestinal health over time and should be checked for other autoimmune conditions.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Lower melatonin levels are linked to more skin aging.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Women with hirsutism have different levels of omentin-1, which may be linked to the condition and its genetic aspects.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

Physicians in China prioritize clinical hyperandrogenism in PCOS treatment, but clearer guidelines are needed.

Hormone levels can help predict metformin treatment success in women with PCOS.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Excess maternal androgens can cause heart problems in offspring.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Iron deficiency may contribute to hair loss.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.